Search Orphan Drug Designations and Approvals
-
| Generic Name: | A therapeutic vaccine targeting the HPV16 E6/E7 proteins |
|---|---|
| Date Designated: | 06/26/2020 |
| Orphan Designation: | Treatment of HPV16-positive cervical cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ISA Therapeutics BV J.H. Oortweg 19 2333 CH Leiden CH Leiden Netherlands The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







